Journal
CLINICAL INFECTIOUS DISEASES
Volume 76, Issue 3, Pages E487-E490Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciac722
Keywords
COVID-19; post-acute sequelae of COVID-19 (PASC); long COVID; SARS-CoV-2 antigens; spike
Categories
Ask authors/readers for more resources
This study analyzed plasma samples from PASC and COVID-19 patients and found that spike protein of SARS-CoV-2 can be detected predominantly in PASC patients for up to 12 months.
The diagnosis of postacute sequelae of coronavirus disease 2019 (PASC) poses an ongoing medical challenge. To identify biomarkers associated with PASC we analyzed plasma samples collected from PASC and coronavirus disease 2019 patients to quantify viral antigens and inflammatory markers. We detect severe acute respiratory syndrome coronavirus 2 spike predominantly in PASC patients up to 12 months after diagnosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available